Letermovir

ADVERTISEMENT

Identification

Molecular formula
C23H11ClF3N3O2
CAS Number
917389-32-3
IUPAC Name
6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
Molecular Weight
477.80g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.4900g/cm3
Synonyms
Rac-Efavirenz
Interesting facts

Interesting Facts about 6-Chloro-4-(2-Cyclopropylethynyl)-4-(Trifluoromethyl)-1H-3,1-Benzoxazin-2-one

This compound is a fascinating example of modern synthetic chemistry, combining unique structural and functional features that hold potential in various applications. Here are some intriguing insights:

  • Structural Diversity: The presence of both a chloro group and a trifluoromethyl group enhances the compound's electronic properties and reactivity, making it a prime candidate for further derivatization in drug design.
  • Cyclopropyl Moiety: The incorporation of a cyclopropyl group is noteworthy. Cyclopropyl rings can impart strain and unique steric effects, influencing biological activity and leading to compounds with enhanced pharmacological profiles.
  • Benzoxazinone Framework: The benzoxazinone structure is recognized for its role in various bioactive compounds, often associated with anti-tumor and anti-inflammatory activities. This suggests potential therapeutic implications for the synthesized compound.
  • Fluorine’s Influence: The trifluoromethyl group not only affects lipophilicity but also helps in modulating the compound's metabolic stability, an important consideration in drug development.
  • Bioactivity Potential: Compounds with such intricate architectures have been studied for their activity against certain cancer cell lines, highlighting their importance in medicinal chemistry research.

As a result of its complex design, 6-Chloro-4-(2-Cyclopropylethynyl)-4-(Trifluoromethyl)-1H-3,1-Benzoxazin-2-one exemplifies how structural modifications can lead to enhanced functional properties. This compound is not only of academic interest but also poses promising avenues for therapeutic innovations.

ADVERTISEMENT